BTHE. Boston Therapeutics Announces Clinical Study Final Results Indicate That SUGARDOWN(R) Reduced the Post-Meal Elevation of Blood Glucose by up to 61% in Healthy Volunteers No Severe Adverse Effects Observed http://finance.yahoo.com/news/boston-therapeutics-announces-clinical-study-123000098.html